This advanced metabolic capsule combines three research compounds with complementary mechanisms: BAM-15 (a mitochondrial uncoupler), SLU-PP-332 (an ERRα/γ nuclear receptor agonist), and C15:0 (pentadecanoic acid, an odd-chain fatty acid with anti-aging properties). BAM-15 was developed as a safer alternative to DNP, achieving metabolic uncoupling without the dangerous hyperthermia associated with older uncouplers. SLU-PP-332 was identified in 2023 research as a potent activator of estrogen-related receptors that mimics the metabolic effects of endurance exercise at the molecular level. C15:0 is a naturally occurring saturated fatty acid found in dairy fat that has been associated in epidemiological studies with reduced all-cause mortality and improved metabolic markers. Together, these three compounds address fat loss, mitochondrial biogenesis, and cellular aging through distinct but synergistic pathways.
One capsule (per prescriber guidance)
“A triple metabolic complex targeting mitochondrial uncoupling, ERR agonism, and cellular aging for comprehensive metabolic optimization.”
BAM-15 uncouples the mitochondrial inner membrane by acting as a proton carrier, dissipating the proton gradient used for ATP synthesis as heat. This increases metabolic rate and fat oxidation without generating excessive reactive oxygen species (ROS), unlike older uncouplers. SLU-PP-332 activates ERRα and ERRγ nuclear receptors, transcription factors that regulate hundreds of genes involved in mitochondrial biogenesis, fatty acid oxidation, and oxidative phosphorylation. C15:0 activates AMPK (the cellular energy sensor), inhibits mTOR (the cellular growth/aging regulator), and has demonstrated anti-inflammatory effects through PPAR-α/δ activation. The combined effect is a comprehensive metabolic reprogramming that increases energy expenditure, improves mitochondrial quality, and reduces markers of cellular aging.
When sourcing BPC-157 for research purposes, the following quality benchmarks should be verified before use.
>98% (verified by HPLC)
Must be provided by supplier
<0.1 EU/mg (prevents bacterial contamination)
Manufactured in cGMP-certified facility
Independent lab verification preferred
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
Early-stage research only. Significant uncertainty about efficacy and safety in humans.
Peptides commonly used alongside BAM-15 + SLU-PP-332 + C15 (Capsule) for synergistic effects.
A small molecule NNMT inhibitor that promotes fat loss and metabolic health by raising cellular NAD+ levels.
An ERRα/γ agonist that mimics the metabolic effects of endurance exercise at the molecular level.
Category
Status
Dose
Frequency
Cycle
Peptides
Protocols
Other Pages
Contact Us Today!
© 2026 Best Health IQ. All rights reserved.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many compounds described on this site are not approved by the FDA for human therapeutic use. Some are available only as compounded preparations or as materials sold for laboratory use, and several are on FDA's Category 2 list for significant safety risks. Nothing on this site constitutes medical advice or a recommendation to use any compound described.
